PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM (CAS:PRO) EV-to-EBIT : 7.74 (As of May. 28, 2025)

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM EV-to-EBIT Chart

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Annual Data
	Trend	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-EBIT		Get a 7-Day Free Trial				6.31	9.08	8.15	10.29	8.39

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Semi-Annual Data
	Jun15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-EBIT	Get a 7-Day Free Trial														8.15	-	10.29	-	8.39

Competitive Comparison of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT falls into.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM EV-to-EBIT Calculation

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT for today is calculated as:

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's current Enterprise Value is MAD768.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was MAD99.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM  (CAS:PRO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Enterprise Value for the quarter that ended in Dec. 2024 was MAD832.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was MAD99.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Business Description